Key result
Single-cell sequencing reveals post-MI molecular heterogeneity and temporal changes to identify potential therapeutic targets.
Why the study?
Heterogeneous changes in cardiomyocytes and non-cardiomyocytes post-MI profoundly impact cardiac repair, and single-cell sequencing can elucidate these mechanisms to identify potential targets for post-infarction remodeling.
Single-cell sequencing provides high-resolution insights into the cellular heterogeneity and dynamic changes of cardiac cells following myocardial infarction, identifying potential therapeutic targets for cardiac repair.
Myocardial infarction (MI) is an important pathological event in cardiovascular disease and the heterogeneous changes in cardiomyocytes and non‑cardiomyocytes that occur following its occurrence have a profound effect on cardiac repair and functional recovery. Single‑cell sequencing, a novel technology for the analysis of tissues at the single‑cell level, permits a comprehensive insight into the heterogeneity of different cell populations. The current review presented a summary of the application of single‑cell sequencing to detect the heterogeneity of cardiomyocytes and non‑cardiomyocytes following MI. It focused on the classification and changes of cell clusters and explored the mechanisms of post‑infarction cardiac regeneration and remodeling with the aim of providing a theoretical foundation for identifying potential targets to enhance the diagnosis and treatment of post‑infarction cardiac remodeling.
No takes yet. Share an insight, caveat, or question.
Bian et al. (2025) conducted a review in Myocardial infarction. Single-cell sequencing was evaluated. Single-cell sequencing reveals significant molecular heterogeneity and temporal changes in cardiomyocytes and non-cardiomyocytes following myocardial infarction, identifying potential therapeutic targets.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: